Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury

Genome Medicine

Volumn 5, Issue 9, 2013, Pages

  Aubrecht, Jiri ^a   Schomaker, Shelli J ^a   Amacher, David E ^b  

^a PFIZER INC   (United States)

^b Toxadvisor Toxicology Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BIOLOGICAL MARKER; CLAVULANIC ACID; FLUCLOXACILLIN; GLUTAMATE DEHYDROGENASE; HLA A ANTIGEN; HLA B ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALATE DEHYDROGENASE; MICRORNA 122; MICRORNA 192; PARACETAMOL; PURINE NUCLEOSIDE PHOSPHORYLASE; STAT4 PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; DRUG INTOXICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIVER INJURY; LIVER TOXICITY; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 84884729694     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm489     Document Type: Article

References (10)

1. Borlak J, Chatterji B, Londhe KB, Watkins PB. Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen induced liver injury. Genome Med 2013, 5:86.
2. Amacher DE, Schomaker SJ, Aubrecht J. Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics. Mol Diagn Ther 2013,
3. Schomaker S, Warner R, Bock J, Johnson K, Potter D, Van Winkle J, Aubrecht J. Assessment of emerging biomarkers of liver injury in human subjects. Toxicol Sci 2013, 132:276-283. 10.1093/toxsci/kft009, 23339181.
4. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013, 58:777-787. 10.1002/hep.26294, 23390034.
5. Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, Craig DG, Simpson KJ, Jaeschke H, Park BK. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012, 56:1070-1079. 10.1016/j.jhep.2011.12.019, 22266604.
6. Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011, 31:1127-1136. 10.1111/j.1478-3231.2011.02528.x, 21745283.
7. Dear JW, Antoine DJ, Starkey-Lewis P, Goldring CE, Park BK. Letter to the Editor: Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis. Br J Clin Pharmacol 2013, doi: 10.1111/bcp.12214.
8. Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP. DILIGEN Study; International SAE Consortium HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009, 41:816-819. 10.1038/ng.379, 19483685, DILIGEN Study; International SAE Consortium.
9. Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe'er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011, 141:338-347. 10.1053/j.gastro.2011.04.001, 3129430, 21570397.
10. Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe'er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB. Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics 2012, 22:784-795. 10.1097/FPC.0b013e3283589a76, 3636716, 22968431, Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium.